A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity
2005 ◽
Vol 16
(2)
◽
pp. 282-288
◽
M.M. Borner
◽
J. Bernhard
◽
D. Dietrich
◽
R. Popescu
◽
M. Wernli
◽
...
2007 ◽
Vol 73
(1-2)
◽
pp. 9-20
◽
Craig Underhill
◽
David Goldstein
◽
Vera A. Gorbounova
◽
Mikhail Y. Biakhov
◽
Igor S. Bazin
◽
...
2018 ◽
Vol 23
(8)
◽
pp. 919-927
◽
Goro Nakayama
◽
Ayako Mitsuma
◽
Yuki Sunagawa
◽
Kiyoshi Ishigure
◽
Hiroyuki Yokoyama
◽
...
2018 ◽
Vol 29
◽
pp. viii202
A. De Stefano
◽
G. Nasti
◽
A. Febbraro
◽
G. Rosati
◽
F. Giuliani
◽
...
2020 ◽
Vol 19
(2)
◽
pp. 109-115
Evaristo Maiello
◽
Gabriele Di Maggio
◽
Stefano Cordio
◽
Saverio Cinieri
◽
Francesco Giuliani
◽
...
2012 ◽
Vol 17
(7)
◽
pp. 937-946
◽
Herbert Hurwitz
◽
Edith P. Mitchell
◽
Thomas Cartwright
◽
Ambrose Kwok
◽
Sylvia Hu
◽
...
2018 ◽
Vol 36
(15_suppl)
◽
pp. 3542-3542
Evaristo Maiello
◽
Gabriele Di Maggio
◽
Stefano Sergio Cordio
◽
Saverio Cinieri
◽
Francesco Giuliani
◽
...
2004 ◽
Vol 22
(14_suppl)
◽
pp. 8120-8120
◽
M. M. Borner
◽
J. Bernhard
◽
D. Dietrich
◽
R. Popescu
◽
M. Wernli
◽
...
2004 ◽
Vol 22
(14_suppl)
◽
pp. 8120-8120
◽
M. M. Borner
◽
J. Bernhard
◽
D. Dietrich
◽
R. Popescu
◽
M. Wernli
◽
...
Close
Export Citation Format
Close
Share Document
Close